Cargando…

Post COVID‐19 vaccination: AusVaxSafety survey participation and adverse events – a community‐based regional Queensland study

OBJECTIVE: To describe adverse events following COVID‐19 immunisation (AEFI) and participation in AusVaxSafety surveillance in a Queensland regional community. METHODS: Participants presenting for second dose COVID‐19 vaccine at the Hervey Bay Wide Bay Hospital and Health Service (WBHHS) vaccine cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamilton, Elizabeth, Oversby, Shannen, Kitchener, Scott, Ratsch, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Covid‐19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874492/ https://www.ncbi.nlm.nih.gov/pubmed/36190203 http://dx.doi.org/10.1111/1753-6405.13300

Ejemplares similares

The short term safety of COVID‐19 vaccines in Australia: AusVaxSafety active surveillance, February – August 2021
por: Deng, Lucy, et al.
Publicado: (2022)

COVID-19 Vaccination: An Exploratory Study of the Motivations and Concerns Detailed in the Medical Records of a Regional Australian Population
por: Hamilton, Elizabeth M, et al.
Publicado: (2022)

Respiratory virus detection during the COVID‐19 pandemic in Queensland, Australia
por: El‐Heneidy, Asmaa, et al.
Publicado: (2021)

Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres
por: Gras-Champel, Valérie, et al.
Publicado: (2021)

Adverse Events Following COVISHIELD Vaccination Among Adult Population in Bangladesh
por: Khalil, Md. Musab, et al.
Publicado: (2021)

Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events
por: Noh, Yunha, et al.
Publicado: (2023)

Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
por: Mariottini, Alice, et al.
Publicado: (2022)

Self-reported adverse events after 2 doses of COVID-19 vaccine in Korea
por: Kwon, Yunhyung, et al.
Publicado: (2022)

Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events
por: Ng, Siew C, et al.
Publicado: (2022)

COVID-19 postvaccination adverse events and vaccine hesitancy among hospital employees: Is there a link?
por: Weiland, Anastasiia, et al.
Publicado: (2022)

Coronavirus Disease 2019: Cardiac Complications and Considerations for Returning to Sports Participation
por: Augustine, Daniel X, et al.
Publicado: (2021)

COVID-19 and Ventilator-Associated Event Discordance
por: Cawcutt, Kelly, et al.
Publicado: (2021)

Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities
por: Manjaly Thomas, Zita-Rose, et al.
Publicado: (2020)

The Impact of COVID-19 on Patient Safety: A Survey of Acute-Care Registered Nurses in New Jersey
por: Pogorzelska-Maziarz, Monika, et al.
Publicado: (2021)

Staying safe while staying together: the COVID‐19 paradox for participants returning to community‐based sport in Victoria, Australia
por: Staley, Kiera, et al.
Publicado: (2021)

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study
por: Mahil, Satveer K., et al.
Publicado: (2021)

Multifocal nivolumab immune-related adverse effects during asymptomatic SARS-CoV-2 infection: causality or casuality?
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Associations of racial and ethnic discrimination with adverse changes in exercise and screen time during the COVID-19 pandemic in the United States
por: Xia, Tong, et al.
Publicado: (2023)

Preparing for and conducting the National Health and Morbidity Survey in Malaysia amid the COVID-19 pandemic: balancing risks and benefits to participants and society
por: Chong, Zhuo Lin, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in the community based on participants in the 2020 Korea National Health and Nutrition Examination Survey
por: Kim, Ah-Ra, et al.
Publicado: (2022)

Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19
por: Villalba, Gonzalo Cabezón, et al.
Publicado: (2021)

Thromboembolism after COVID-19 Vaccination: A Systematic Review of Such Events in 286 Patients
por: Mani, Avinash, et al.
Publicado: (2022)

Safety of urologic elective surgery in a covid-hospital
por: Blezien, O., et al.
Publicado: (2020)

Avoiding a crisis at Christmas: a systematic review of adverse health effects or ‘Chrishaps’ caused by traditional hazard sources and COVID‐19
por: Wild, Ursula, et al.
Publicado: (2022)

Junior doctors’ mental health and coronavirus disease safety concerns
por: Bartholomew, Alexandra, et al.
Publicado: (2022)

Maternal COVID-19, vaccination safety in pregnancy, and evidence of protective immunity
por: Pham, Amelie, et al.
Publicado: (2021)

Safety of COVID-19 vaccine in patients with epilepsy: a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2022)

An observational study on the safety of COVID-19 vaccination in patients with myasthenia gravis
por: Wang, H.Y., et al.
Publicado: (2023)

Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients
por: Yachou, Yassine, et al.
Publicado: (2020)

Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine—a case report
por: Consoli, Stefano, et al.
Publicado: (2021)

Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19
por: Leeson, Cale E., et al.
Publicado: (2020)

Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysis
por: Tao, Jun, et al.
Publicado: (2021)

Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD
por: Kim, Sohyeon, et al.
Publicado: (2023)

Impact of COVID-19 on Antimicrobial Use and Resistance in an Urban Safety-Net Community Hospital
por: Lora, Alfredo Mena, et al.
Publicado: (2021)

COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation
por: Trinchillo, Assunta, et al.
Publicado: (2022)

Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19
por: Papi, Alberto, et al.
Publicado: (2023)

Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2023)

Parental concerns about COVID-19 vaccine safety and hesitancy in Korea: implications for vaccine communication
por: Cho, Hye-Kyung, et al.
Publicado: (2022)

Principles of Disinfectant Use and Safety Operation in Medical Facilities During Coronavirus Disease 2019 (COVID-19) Outbreak
por: Takagi, Gen, et al.
Publicado: (2020)

Immunogenicity and Safety of Standard and Third‐Dose SARS–CoV‐2 Vaccination in Patients Receiving Immunosuppressive Therapy
por: Syversen, Silje W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h0si5dqg306spk7s6ct3dmc3sp